Organigram Global (OGI) Change in Working Capital (2024 - 2026)

Organigram Global (OGI) posted quarterly Change in Working Capital of -$21.5 billion for Q1 2026, down 323.52% year-on-year from $9.6 billion in Q1 2025, and down 143828307.77% on a QoQ basis from -$14920.4 in Q4 2025.

Organigram Global (OGI) Change in Working Capital (2024 - 2026) Analysis & Trends

Organigram Global (OGI) has reported Change in Working Capital for 3 consecutive years, with -$21.5 billion the latest figure, recorded in Q1 2026.

  • Quarterly Change in Working Capital fell 323.52% year-over-year to -$21.5 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$11.9 billion (changed N/A YoY) and the FY2020 annual result came in at $141123.0, changed N/A from the prior year.
  • Change in Working Capital fell to -$21.5 billion in Q1 2026 per OGI's latest filing, from -$14920.4 in the prior quarter.
  • Over the last five years, Change in Working Capital for OGI reached as high as $9.6 billion in Q1 2025 and fell as low as -$21.5 billion in Q1 2026.
  • A 3-year average of -$3.0 billion and a median of -$31060.0 in 2025 frame the typical range for Change in Working Capital.
  • Annual changes were most pronounced in 2025 — Change in Working Capital surged 68.39% — and 2026, when it plunged 323.52%.
  • Year by year, Change in Working Capital stood at -$47199.5 in 2024, then jumped by 68.39% to -$14920.4 in 2025, then plunged by 143828307.77% to -$21.5 billion in 2026.
  • According to Business Quant data, Change in Working Capital over the past three periods registered -$21.5 billion, -$14920.4, and $9.6 billion for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -617.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 Organigram Global 89.89 Mn 122.96 Mn 28.97 Mn -21.46 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -21.46 Bn
Mar 31, 2026 -21.46 Bn
Dec 31, 2025 -14,920.41
Dec 31, 2025 -14,920.41
Mar 31, 2025 9.60 Bn
Mar 31, 2025 9.60 Bn
Dec 31, 2024 -47,199.51
Dec 31, 2024 -47,199.51